Agreement dated August 12, 2020 between Immune Therapeutics, Inc. and Cytocom, Inc. assigning all of .Immune Therapeutics right, title and interest in LDN and MENK in Developing Markets and the License to those products to Cytocom, and related matters
Contract Categories:
Intellectual Property
- License Agreements
EX-10.73 2 ex10-73.htm
Exhibit 10.73
